NIRVF (Nirvana Life Sciences) Accounts Payable: $0.12 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nirvana Life Sciences Accounts Payable?

Nirvana Life Sciences NIRVF Accounts Payable is $0.12 Mil as of Jan. 2026. The stock has 3 warning signs investors should review.

Nirvana Life Sciences's Accounts Payable for the quarter that ended in Jan. 2026 was $0.12 Mil.

Nirvana Life Sciences's quarterly Accounts Payable declined from Jul. 2025 ($0.15 Mil) to Oct. 2025 ($0.12 Mil) but then increased from Oct. 2025 ($0.12 Mil) to Jan. 2026 ($0.12 Mil).

Nirvana Life Sciences's annual Accounts Payable increased from Apr. 2023 ($0.13 Mil) to Apr. 2024 ($0.13 Mil) and increased from Apr. 2024 ($0.13 Mil) to Apr. 2025 ($0.18 Mil).

Nirvana Life Sciences Accounts Payable Related Terms

Nirvana Life Sciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Nirvana Life Sciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences Accounts Payable Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23 Apr24 Apr25
Accounts Payable
Get a 7-Day Free Trial 0.01 0.06 0.13 0.13 0.18

Nirvana Life Sciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.18 0.15 0.12 0.12

Nirvana Life Sciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.12 Mil mean?
Nirvana Life Sciences (NIRVF) has a Accounts Payable of $0.12 Mil as of Jan. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Nirvana Life Sciences and its competitors.
Is Nirvana Life Sciences' Accounts Payable too high?
Nirvana Life Sciences' current Accounts Payable is $0.12 Mil.
How does Nirvana Life Sciences' Accounts Payable compare to VRTX and REGN?
Nirvana Life Sciences' Accounts Payable of $0.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Nirvana Life Sciences and its competitors. Nirvana Life Sciences's current Accounts Payable is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirvana Life Sciences stock overvalued right now?
Nirvana Life Sciences (NIRVF) has a current Accounts Payable of $0.12 Mil. The current Accounts Payable is $0.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Nirvana Life Sciences (NIRVF), the current Accounts Payable is $0.12 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nirvana Life Sciences Business Description

Other Exchanges NIRV.X:Canada
Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.